MIMEDX GROUP INC Shareholder Call To Update Progress Of FDA Discussions, Reimbursement Successes And Recent Short-Selling Initiatives Mar 25, 2014 from 11:00 AM to 11:00 AM EDT Click here for webcast Live Teleconference Information Primary # - 800 299.9630 Secondary # - 617 786.2904 Passcode - 77816887
